MET gene copy number gains evaluated by NGS is more predictive than other methods to enrich for papillary RCC patients sensitive to savolitinib, a selective MET inhibitor (AACR 2018)

Melanie M. Frigault, Sabina Signoretti, Aleksandra Markovets, Daniel Stetson, William Howat, Martine Roudier, Vincent Haddad, Brian Dougherty, Toni K. Choueiri, J. Carl Barrett



Venue: American Association for Cancer Research Annual Meeting in Chicago, Illinois, USA

Abstract #: 4541

Session: Poster Session – Section 24 Diagnostic Biomarkers

Date: Tuesday, April 17, 2018

Location: Exhibit Hall A, McCormick Place South (Level 3)


Download Poster (PDF)